Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations
Clin Infect Dis
.
2021 Jan 27;72(2):254-256.
doi: 10.1093/cid/ciaa1116.
Authors
Michael P Busch
1
,
Mars Stone
1
Affiliation
1
Vitalant Research Institute, Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
PMID:
33501953
PMCID:
PMC7454349
DOI:
10.1093/cid/ciaa1116
No abstract available
Keywords:
SARS-CoV-2; antibodies; blood donors; seroincidence; seroprevalence.
Publication types
Editorial
Comment
MeSH terms
Blood Donors
COVID-19*
Humans
Immunologic Tests
Incidence
SARS-CoV-2*